Profound Medical Corp. — Form 10-Q
Filed August 6, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 3/100
What the filing says
CEO Arun Menawat and CFO Rashed Dewan certified the Q2 2026 10-Q (period ended June 30, 2026) on August 6, 2026, attesting that disclosure controls, financial reporting controls, and financial statements are effective and fairly presented. No material weaknesses, significant deficiencies, or fraud were disclosed. This is routine boilerplate certification required by Sarbanes-Oxley.
Why this rating
Standard mandatory SOX certifications; no operational, financial, or strategic developments disclosed. Routine periodic filing requirement.
See more from August 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.